Antibodies directed to angiopoietin-2 and uses thereof
AssigneeMedImmune, LLC
InventorsLarry L. Green, Qing Zhou, Bruce A. Keyt, Xiao-Dong Yang, Stephen Charles Emery, David Charles Blakey
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedImmune, LLC
InventorsLarry L. Green, Qing Zhou, Bruce A. Keyt, Xiao-Dong Yang, Stephen Charles Emery, David Charles Blakey
Estimating the term…
Antibodies directed to the antigen Ang-2 and uses of such antibodies are described. In particular, fully human monoclonal antibodies directed to the antigen Ang-2. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.
A targeted binding agent that binds to Angiopoietin-2 with a Kd of less than 100 picomolar (pM).
2-10. (canceled)
12-13. (canceled)
25-34. (canceled)
Dependencies are inferred from the claim text.